Neurescence Revenue and Competitors
Estimated Revenue & Valuation
- Neurescence's estimated annual revenue is currently $930k per year.
- Neurescence's estimated revenue per employee is $155,000
Employee Data
- Neurescence has 6 Employees.
- Neurescence grew their employee count by -33% last year.
Neurescence's People
Name | Title | Email/Phone |
---|
Neurescence Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.7M | 9 | -72% | $39.4M | N/A |
#2 | $0.9M | 11 | -83% | $23.8M | N/A |
#3 | $87.6M | 565 | 6% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $7.8M | 50 | -68% | N/A | N/A |
#6 | $13.5M | 87 | 30% | N/A | N/A |
#7 | $17.8M | 115 | -6% | N/A | N/A |
#8 | $0.9M | 11 | -39% | N/A | N/A |
#9 | $13.6M | 88 | -20% | $86M | N/A |
#10 | $20M | 129 | -12% | N/A | N/A |
What Is Neurescence?
Neurescence has created and commercialized a miniature microscope for functional imaging of neuronal circuits. The Quartet® is a hardware-software system and the only technology that enables a causal connection between neuronal short and long rage circuitry and disease phenotype. Our initial target market is neuroscience research and we are concurrently pursuing its use in CNS commercial drug development. We combine the power of novel optical imaging technology with advanced machine learning and quantum machine learning techniques to enhance neurodegenerative, motor and mood disorder drug development.
keywords:N/AN/A
Total Funding
6
Number of Employees
$930k
Revenue (est)
-33%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Neurescence News
This strategic branding led to a LinkedIn invite from the CEO of Neurescence, a biological optical imaging company, which hired her as a...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.2M | 6 | 0% | N/A |
#2 | $0.4M | 6 | -33% | $6M |
#3 | $1.7M | 6 | -14% | N/A |
#4 | $1.2M | 6 | 0% | N/A |
#5 | $0.4M | 6 | N/A | N/A |